Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects

NCT06005714 is registered in ClinicalTrials.gov with Shanghai Vinnerna Biosciences Co., Ltd. as lead sponsor.

NCT NCT06005714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06005714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects
Lead sponsor
Shanghai Vinnerna Biosciences Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
August 15, 2023
Completion date
October 31, 2023
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the effects of clarithromycin or cyclosporine on pharmacokinetics of deuterium hydrobromide ramidvir tablets in healthy chinese subjects